Health care resource utilization and treatment variability in the care of patients with advanced or metastatic colorectal or gastric cancer.

Statistically significant relationships were observed between treatment variability as measured by HHI and increased HCRU, but no consistent directional trends in HCRU variables were observed. Therefore, this study failed to reject the null hypothesis of equivalent HCRU by level of treatment variability.